EP1991292A1 — Adipose tissue regeneration kit and its using method
Assigned to Cellontech Co Ltd · Expires 2008-11-19 · 17y expired
What this patent protects
Provided is a kit for adipose tissue regeneration and a method of using the same. For this purpose, the present invention provides a kit for adipose tissue regeneration constituted in the form of a single set kit (10), wherein the bottom of a kit box equipped with a locking devic…
USPTO Abstract
Provided is a kit for adipose tissue regeneration and a method of using the same. For this purpose, the present invention provides a kit for adipose tissue regeneration constituted in the form of a single set kit (10), wherein the bottom of a kit box equipped with a locking device is provided with a washing container (22) filled with an aseptic and sterile solution for washing adipose tissues and a washing container insertion groove (13) for containing the same; a first syringe container (20) containing first syringes (30) for washing and separation of adipose tissues, injection of the wash solution and mixing of a Bio-Gel, respectively, and an first syringe container insertion groove (11) for containing the same; a second syringe container (21) containing a plurality of second Bio-Gel syringes (40) filled with biocompatible materials to promote adi-pogenesis induction and a second syringe container insertion groove (12) for containing the same; and connector containers (23) containing connectors (60) for use in injection of the wash solution and mixing of washed adipose tissues and biocompatible materials, and connector container insertion grooves (14) for containing the same, and wherein the top of the kit box is provided with needle containers (24) containing transplantation needles (50) and needle container insertion grooves (15) for containing the same; and a protocol (25) in which standardization of fat transplantation is defined and a protocol insertion groove (16) for containing the same.
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.